Understanding the pathogenesis of uveitis in Ebola virus disease survivors: a study protocol for clinical, molecular virologic, and immunologic characterization.

Saved in:
Bibliographic Details
Title: Understanding the pathogenesis of uveitis in Ebola virus disease survivors: a study protocol for clinical, molecular virologic, and immunologic characterization.
Authors: Hartley CD; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Linderman S; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, United States of America.; Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America., Fashina T; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Ward L; Emory University Rollins School of Public Health, Atlanta, Georgia, United States of America., Drews-Botsch C; College of Public Health, George Mason University Fairfax, Virginia, United States of America., Pratt C; Biosurv International, Salisbury, England, United Kingdom., Kuthyar S; Emory University School of Medicine, Atlanta, Georgia, United States of America., Fernandes AF; Emory University School of Medicine, Atlanta, Georgia, United States of America., Huang Y; Department of Ophthalmology, University of Illinois Chicago, Chicago, Illinois, United States of America., Choo C; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Nguyen N; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Carag J; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America., Morgan J; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America., Kraft CS; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America., Hewlett A; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.; Global Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Brett-Major D; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.; Global Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.; Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Schieffelin JS; Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Garry RF; Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Grant D; Kenema Government Hospital Lassa Hemorrhagic Fever Lab, Kenema, Sierra Leone., Justin GA; Walter Reed National Army Medical Center, Washington, D.C. United States of America., Conrady CD; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Smith JR; College of Medicine and Public Health, Flinders University, Adelaide, Australia., Hayek BR; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Balendra S; University College London, London, United Kingdom., Acharya N; F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America., Doan T; F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America., Legand A; World Health Organization, Geneva, Switzerland., Formenty P; World Health Organization, Geneva, Switzerland., Zeng X; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America., Conteh I; Ministry of Health, Freetown, Sierra Leone., Vandy MJ; Ministry of Health, Freetown, Sierra Leone., Harrison-Williams L; Ministry of Health, Freetown, Sierra Leone., Mustapha J; Ministry of Health, Freetown, Sierra Leone., Koroma Z; Ministry of Health, Freetown, Sierra Leone., Wiley M; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America., Crozier I; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America., Mwanza JC; University of North Carolina-Chapel Hill, Chapel Hill, NC, United States of America., Shantha JG; F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America., Ahmed R; Emory Vaccine Center, Emory University, Atlanta, Georgia, United States of America., Yeh S; Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.; Emory University School of Medicine, Atlanta, Georgia, United States of America.; Global Center for Health Security, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Corporate Authors: SMILE and EVICT-VR Investigator Study Groups
Source: MedRxiv : the preprint server for health sciences [medRxiv] 2025 May 21. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
DOI:10.1101/2025.05.19.25327799